The effect of dydrogesterone and vaginal progestrein in support of artificial reproduction techniques

Comparison of the efficacy of two therapeutic methods of use of dydrogesterone and vaginal progestrein as a luteal cycles support in Assisted Reproductive Technology (ART) in patients referring to Fateme Zahra infertility center in Babol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170205032406N2

Enrollment

210

Registered

2018-10-15

Start date

2018-10-02

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In vitro fertilization. Complications of attempted introduction of fertilized ovum following in vitro fertilization

Interventions

Intervention 1: Control group: Receives 400 mg vaginal suppository once a day began on the day of oocyte retrieval and was continued up to 12 weeks of pregnancy. Intervention 2: Intervention group: re

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 20-40 years old Body Mass Index 18-30 kg/m2 Endometrium Thickness 7-14 mm

Exclusion criteria

Exclusion criteria: Abnormal prolactin serum level and abnormal thyroid function test Diminished ovarian reserve ( baseline FSH level >10 IU/mL)

Design outcomes

Primary

Measure	Time frame
Pregnancy. Timepoint: Once a week after embryo transfer into the patient. Method of measurement: The blood hCG test.	—

Secondary

Measure	Time frame
Preterm delivery. Timepoint: Every two weeks from the twentieth week of pregnancy. Method of measurement: Patient visit and record uterine contractions.;Amount of live birth. Timepoint: Every two weeks from twenty-eighth week of pregnancy. Method of measurement: Patient visit and record baby's birth.;Abortion. Timepoint: Six weeks after intervention. Method of measurement: Sonography and pregnancy test.	—

Measure

Time frame

Preterm delivery. Timepoint: Every two weeks from the twentieth week of pregnancy. Method of measurement: Patient visit and record uterine contractions.;Amount of live birth. Timepoint: Every two weeks from twenty-eighth week of pregnancy. Method of measurement: Patient visit and record baby's birth.;Abortion. Timepoint: Six weeks after intervention. Method of measurement: Sonography and pregnancy test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shahla Yazdani

Babol University of Medical Sciences

shahla_yazdani_1348@yahoo.com+98 11 3223 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026